DK0862622T3 - Fremgangsmåde til identifikation af forbindelser, der vekselvirker med RAC-proteinkinase - Google Patents

Fremgangsmåde til identifikation af forbindelser, der vekselvirker med RAC-proteinkinase

Info

Publication number
DK0862622T3
DK0862622T3 DK96938081T DK96938081T DK0862622T3 DK 0862622 T3 DK0862622 T3 DK 0862622T3 DK 96938081 T DK96938081 T DK 96938081T DK 96938081 T DK96938081 T DK 96938081T DK 0862622 T3 DK0862622 T3 DK 0862622T3
Authority
DK
Denmark
Prior art keywords
rac
protein kinase
interact
screening
modulators
Prior art date
Application number
DK96938081T
Other languages
English (en)
Inventor
Philip Cohen
Dario Alessi
Darren Cross
Mirjana Andjelkovic
Brian Arthur Hemmings
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9523379.7A external-priority patent/GB9523379D0/en
Priority claimed from GBGB9525704.4A external-priority patent/GB9525704D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0862622T3 publication Critical patent/DK0862622T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK96938081T 1995-11-16 1996-11-05 Fremgangsmåde til identifikation af forbindelser, der vekselvirker med RAC-proteinkinase DK0862622T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9523379.7A GB9523379D0 (en) 1995-11-16 1995-11-16 Compound and method
GBGB9525704.4A GB9525704D0 (en) 1995-12-15 1995-12-15 Ligand and screening method
EP96938081A EP0862622B1 (en) 1995-11-16 1996-11-05 Method of screening for RAC protein kinase interacting compounds

Publications (1)

Publication Number Publication Date
DK0862622T3 true DK0862622T3 (da) 2004-12-20

Family

ID=26308124

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96938081T DK0862622T3 (da) 1995-11-16 1996-11-05 Fremgangsmåde til identifikation af forbindelser, der vekselvirker med RAC-proteinkinase

Country Status (9)

Country Link
EP (1) EP0862622B1 (da)
JP (1) JP4173544B2 (da)
AT (1) ATE274053T1 (da)
AU (1) AU7564396A (da)
DE (1) DE69633186T2 (da)
DK (1) DK0862622T3 (da)
ES (1) ES2227614T3 (da)
PT (1) PT862622E (da)
WO (1) WO1997018303A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9525703D0 (en) * 1995-12-15 1996-02-14 Ciba Geigy Ag Screening method
US6057117A (en) * 1996-04-04 2000-05-02 Chiron Corporation Identification and use of selective inhibitors of glycogen synthase kinase 3
CA2214841A1 (en) * 1997-10-31 1999-04-30 Lisa Mckerracher Rho antagonists and their use to block inhibition of neurite outgrowth
SE9801530D0 (sv) * 1998-04-30 1998-04-30 Pharmacia & Upjohn Ab Method for screening
US6555732B1 (en) 1998-09-14 2003-04-29 Pioneer Hi-Bred International, Inc. Rac-like genes and methods of use
DE69941877D1 (de) * 1998-10-16 2010-02-11 Otsuka Pharma Co Ltd Neovaskular-spezifische peptide
US7169783B2 (en) 1998-11-02 2007-01-30 Universite De Montreal (+)-Trans-4-(1-aminoethyl)-1-(4-pyridycarbamoyl)-cyclohexane and method for promoting neural growth in the central nervous system and in a patient at a site of neuronal lesion
GB9828375D0 (en) * 1998-12-22 1999-02-17 Janssen Pharmaceutica Nv Human akt-3
WO2000050452A1 (en) * 1999-02-26 2000-08-31 University College London Mutants of rac protein
US6881555B2 (en) 1999-03-19 2005-04-19 Aventis Pharmaceuticals Inc. AKT nucleic acids, polypeptides, and uses thereof
WO2000056866A2 (en) * 1999-03-19 2000-09-28 Aventis Pharmaceuticals Products Inc. Akt-3 nucleic acids, polypeptides, and uses thereof
US20040096448A1 (en) * 2000-05-30 2004-05-20 Karin Molling Nucleic acid molecules encoding a protein interacting with ser/thr kinase akt
US6689807B1 (en) 2000-06-08 2004-02-10 Caritas St. Elizabeth's Medical Center Of Boston, Inc. HMG CoA reductase inhibitors for promoting angiogenesis
GB0014185D0 (en) * 2000-06-09 2000-08-02 Novartis Res Found Compound and method
AU2003284981B2 (en) 2002-10-30 2009-05-28 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
GB0227562D0 (en) 2002-11-26 2002-12-31 Novartis Forschungsstiftung Phorphorylated NDR Kinase
AU2005287169A1 (en) * 2004-09-17 2006-03-30 Exelixis, Inc. PIK4CA as modifier of the RAC pathway and methods of use
CA2922575C (en) * 2013-11-01 2022-10-11 Newsouth Innovations Pty Limited Pharmaceutical combinations for the treatment of cancer

Also Published As

Publication number Publication date
AU7564396A (en) 1997-06-05
ES2227614T3 (es) 2005-04-01
DE69633186D1 (de) 2004-09-23
DE69633186T2 (de) 2005-08-18
EP0862622A1 (en) 1998-09-09
ATE274053T1 (de) 2004-09-15
JP2000500746A (ja) 2000-01-25
JP4173544B2 (ja) 2008-10-29
WO1997018303A1 (en) 1997-05-22
EP0862622B1 (en) 2004-08-18
PT862622E (pt) 2005-01-31

Similar Documents

Publication Publication Date Title
DK0862622T3 (da) Fremgangsmåde til identifikation af forbindelser, der vekselvirker med RAC-proteinkinase
ATE279203T1 (de) Verwendung von substrat-subtraktionsbibliotheken zur unterscheidung von enzymspezifitäten
WO2004037159A3 (en) Compounds, compositions and methods for modulating fat metabolism
DK1143955T3 (da) En kombination af FBPase-inhibitorer og insulinsensibiliseringsmidler til behandling af diabetes
DK1112275T3 (da) Hidtil ukendte heteroaromatiske inhibitorer for fructose-1,6-bisphosphatase
NO20052923L (no) Fusjonerte bicykliske nitrogeninneholdende heteroringer
DE69736351D1 (de) Methoden und mittel zur hemmung der cdk4-aktivität
WO2003099781A3 (en) METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES
TW200504223A (en) Methods of assessment of drug metabolizing enzymes
DE69637391D1 (de) Modifizierte myelin proteinmoleküle
DK0507831T3 (da) Fremgangsmåde til detektion af knogle- og bindevævssygdomme hos mennesker og dyr
ATE238551T1 (de) Homogene nachweisverfahren zur bestimmung der phosphorylierungsaktivitäten von biologischem material
DE69733861D1 (de) Verwendung von neuronalem apoptose-inhibitorprotein
Liu et al. The signaling protein Rho is necessary for vascular smooth muscle migration and survival but not for proliferation
Ritchie et al. Characterization of crosslinking sites in fibrinogen for plasminogen activator inhibitor 2 (PAI‐2)
ATE256120T1 (de) Reagentien für cyp2d fluoreszenztest
DK1169058T3 (da) Insulinlignende vækstfaktorbindingsprotein-4-protease
DE69837148D1 (de) Chimäre proteine zur behandlung von diabetes
DE69826717D1 (de) Target zur behandlung von atherosklerose, fettleibigkeit und diabetis typ ii
WO2002093127A3 (en) Methods and reagents for identifying insulin response modulators and therapeutic uses therefor
WO2003012103A3 (fr) Acides nucleiques codant de nouvelles proteines a boite f, leurs utilisations en diagnostic et en therapie
DK0864092T3 (da) Kompleks-bundne inhibitorer af aktiverbare stofskifteenzymer som molekylære markører til diagnosticering og terapiovervågning
SE9803958D0 (sv) Method for screening
BR9914090A (pt) ácidos nucléicos codificando uma sub-unidade gama da proteìna g envolvida em transdução sensorial
WO2003012102A3 (fr) Acides nucleiques codant des proteines a domaine hect